Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2022. Read More.
Open Access Percentage
61%
Total
Publications
4.3K
Total Open
Publications
2.7K
Total
Citations
191K
Open Access
Percentage
61%
Total
Publications
4.3K
Total Open
Publications
2.7K
Total
Citations
191K
Breakdown
Publisher Open
14%
Both
34%
Other Platform Open
14%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
750
Hybrid 22%
446
No Guarantees 42%
873
Other Platform Open
Domain 92%
1.9K
Public 13%
268
Institution 13%
263
Other Internet 6%
118
Preprint 5%
113
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.9K |
Europe PMC | Domain | 1.5K |
Semantic Scholar | Public | 234 |
bioRxiv | Preprint | 75 |
DOI | Other Internet | 51 |
Figshare | Public | 44 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 38 |
CiteSeer X | Other Internet | 35 |
medRxiv | Preprint | 20 |
Zenodo | Public | 18 |